Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SHIP: Hypertonic Saline in Preschoolers
NCT02378467Completed
- Sponsor
- University of Washington
- Start
- Mar 2015
- Primary completion
- Aug 2018
- Modality
- Small Molecules, Device-based Delivery
- Countries
- 2
01
Overview
Randomised, double-blind trial of hypertonic saline in cystic fibrosis (CF) (2 arms), sponsored by University of Washington. Primary endpoint: Change in Lung Clearance Index at 48 weeks. Started Mar 2015; status: completed.
02
Drugs
hypertonic saline
03
Conditions
cystic fibrosis (CF)
Beyond the preview
Go deeper on NCT02378467.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02378467.